Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease?

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 9, 2007, Pages 1079-1086

  Gerson, L B ^a,d   Ullah, N ^a   Fass, R ^b   Green, C ^b   Shetler, K ^c   Singh, G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CAUCASIAN; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE DURATION; ESOPHAGUS PH; FAMILY HISTORY; FEMALE; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PH MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; BARRETT ESOPHAGUS; BODY MASS INDEX; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34247151579     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03290.x     Document Type: Article

References (29)

1. Gallup Organization. Heartburn across America: A Gallup Organization national survey. Princeton, NJ: Gallup Organization, 1988.
2. Nebel OT, Forbes MF, Castell DO. Symptomatic GE reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-6.
3. Reid BJ, Weinstein WM. Barrett's esophagus and adenocarcinoma. Annu Rev Med 1987; 38: 477-92.
4. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. NEJM 1999; 340: 825-31.
5. Gerson LB, Edson R, Lavori PW, Triada-filopoulos G. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 2001; 96: 2005-12.
6. Falk GW. Endoscopic surveillance of Barrett's esophagus: risk stratification and cancer risk. Gastrointest Endosc 1999; 49: S29-34.
7. El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005; 100: 2151-6.
8. Lieberman DA, Oehlke M, Helfand M., et al. Risk factors for Barrett's esophagus in community-based practice GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy.. Am J Gastroenterol 1997; 92: 1293-7.
9. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006; 354: 2340-8.
10. Stein DJ, El-Serag HB, Kuczynski J, Kramer JR. The Association of Body Mass Index with Barrett's Esophagus. Aliment Pharmacol Therap 2005; 22: 1005-10.
11. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883-90.
12. Triadafilopoulos G, Sharma R. Features of symptomatic gastroesophageal reflux disease in elderly patients. Am J Gastroenterol 1997; 92: 2007-11.
13. Drossman DA, Sandler RS, McKee DC, et al. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982; 83: 529-34.
14. SAS 9.1 for Windows. Cary Institute 2002-2003. Cary, NC: SAS 9.1 for Windows.
15. Agresti A. An Introduction to Categorical Data Analysis. New York: John Wiley & Sons, Inc., 1996.
16. Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc February 2005; 61: 226-31.
17. Spechler SJ, Jain SK, Tendler DA, Parker RA. Racial differences in the frequency of symptoms and complications of gastrooesophageal reflux disease. Aliment Pharmacol Ther 2002; 16: 1795-800.
18. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol Jun 2005; 100: 1243-50.
19. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
20. Vaughan TL, Kristal AR, Blount PL, et al. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2002; 11: 745-52.
21. Metcalfe C, Davey Smith G, Sterne JA, Heslop P, Macleod J, Hart CL. Causespecific hospital admission and mortality among working men: association with socioeconomic circumstances in childhood and adult life, and the mediating role of daily stress. Eur J Public Health 2005; 15: 238-44.
22. Malcolm CA, MacKay WG, Shepherd A, Weaver LT. Helicobacter pylori in children is strongly associated with poverty. Scott Med J 2004; 49: 136-8.
23. Jansson C, Johansson AL, Nyren O, Lagergren J. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14: 1754-61.
24. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related risk factors in the etiology of gastroesophageal reflux. Gut 2004; 53: 1730-1735.
25. Wang J, Luo J, Dong L, Gong J, Tong M. Epidemiology of gastroesophageal reflux disease: A general population - based study in Xi'an of Northwest China. World J Gastroenterol 2004; 10: 1647-1651.
26. Caygill CP, Johnston DA, Lopez M, et al. Lifestyle factors and Barrett's esophagus. Am J Gastroenterol 2002; 97: 1328-31.
27. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
28. Gopal DV, Lieberman DA, Magaret N, et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci 2003; 48: 1537-41.
29. Chak A, Faulx A, Kinnard M, et al. Identification of Barrett's esophagus in relatives by endoscopic screening. Am J Gastroenterol 2004; 99: 2107-14.